Valuation: TransMedics Group, Inc.

Market Cap 3.07B 2.65B 2.49B 2.27B 4.26B 294B 4.33B 29.21B 11.42B 147B 11.53B 11.28B 489B P/E 2026 *
63.2x
P/E 2027 * 39.8x
Enterprise Value 3.03B 2.62B 2.46B 2.24B 4.21B 290B 4.28B 28.83B 11.27B 145B 11.38B 11.13B 482B EV / Sales 2026 *
4.09x
EV / Sales 2027 * 3.34x
Free-Float
96.36%
Yield 2026 *
-
Yield 2027 * -
1 day-1.32%
1 week+5.45%
Current month+15.62%
1 month+18.59%
3 months+42.59%
6 months-31.87%
Current year-27.28%
1 week 81.77
Extreme 81.7723
90.09
1 month 68
Extreme 68
90.09
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 01/08/1998
Director of Finance/CFO 55 02/12/2024
Chief Operating Officer 43 02/02/2023
Director TitleAgeSince
Director/Board Member 57 01/08/1998
Chairman 81 01/01/2011
Director/Board Member 78 01/02/2016
Date Insider Type Main position Quantity % Market Cap.
7/10/26 A Free

Chief Financial Officer

43,399 0.1273%
7/10/26 A Free

Chief Operating Officer

29,511 0.0866%
7/10/26 A Free

Founder

162,653 0.4771%
Change 5-day change 1-year change 3-year change Capi.($)
-1.32%+5.45%-31.82%+41.31% 3.07B
-1.28%-0.96%+21.29%+8.87% 218B
-0.71%-1.13%-3.70%-21.28% 142B
-1.68%+4.14%-17.31%+29.31% 139B
+0.27%+5.11%-50.24%+0.97% 75.11B
-1.04%+2.10%+17.17%+13.75% 52.8B
+0.69%-0.51%-15.97%-16.56% 50.66B
-0.51%+1.75%+24.95%+17.28% 41.95B
-0.32%+1.31%+40.42%+42.93% 40.49B
-0.14%+2.68%+0.04%+2.63% 33.28B
Average -0.22%+2.15%-1.52%+11.92% 79.66B
Weighted average by Cap. -0.15%+1.24%+0.76%+7.06%

Financials

2026 *2027 *
Net sales 742M 641M 602M 547M 1.03B 70.92B 1.05B 7.05B 2.76B 35.52B 2.78B 2.72B 118B 875M 756M 710M 646M 1.21B 83.64B 1.23B 8.32B 3.25B 41.89B 3.28B 3.21B 139B
Net income 52.34M 45.21M 42.48M 38.64M 72.64M 5.01B 73.84M 498M 195M 2.51B 197M 192M 8.33B 90.29M 77.99M 73.28M 66.65M 125M 8.63B 127M 859M 336M 4.32B 339M 332M 14.37B
Net Debt -40.26M -34.77M -32.67M -29.72M -55.87M -3.85B -56.79M -383M -150M -1.93B -151M -148M -6.41B -146M -126M -118M -108M -202M -13.93B -205M -1.39B -542M -6.97B -547M -535M -23.18B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
14/08/26 $88.58 -1.18% 434,039
13/08/26 $89.64 +3.01% 710,228
12/08/26 $87.02 -2.62% 696,210
11/08/26 $89.36 +1.07% 876,735
10/08/26 $88.41 +5.39% 1,356,286
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
88.58USD
Average target price
97.30USD
Spread / Average Target
+9.84%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock